What are the opening hours?

Monday 9am - 5pm Tuesday 9pm - 5am Wednesday 9am - 5am Thursday 9am - 5am Sunday 9am - 5pm

Reme-D

Reme-D, where innovation and science intersect to bring you unparalleled diagnostic solutions.

10/29/2026

🔬💡 عندك فكرة ممكن تطوّر مستقبل المعامل الطبية؟ فرصتك تبدأ من هنا!
تعلن المعامل المركزية للصحة العامة عن فتح باب المشاركة في 🏆 Lab Innovation Competition 2026، المسابقة العلمية المخصصة لطلاب كليات تكنولوجيا العلوم الصحية والعلوم الصحية التطبيقية، لتشجيع الأفكار المبتكرة التي تسهم في تطوير منظومة العمل داخل المعامل الطبية وتحسين جودة الخدمات الصحية.
🚀 حوّل فكرتك إلى حل مبتكر!
لو عندك فكرة تساعد في:
🔹 تطوير بيئة العمل داخل المعامل.
🔹 تقليل زمن إجراء التحاليل (TAT).
🔹 رفع كفاءة التشغيل وتحسين استخدام الموارد.
🔹 ابتكار حلول ذكية للتحول الرقمي وأتمتة العمليات.
🔹 تحقيق الاستدامة وتطوير جودة المخرجات.
دي فرصتك إنك تعرض فكرتك وتكون جزءًا من مستقبل الابتكار في القطاع الصحي! 🧬
🎁 الجوائز المقدمة برعاية REME-D:
🥇 المركز الأول: 10,000 جنيه مصري
🥈 المركز الثاني: 7,000 جنيه مصري
🥉 المركز الثالث: 3,000 جنيه مصري
📅 موعد المؤتمر: 26–27 ديسمبر 2026
⏳ آخر موعد للتقديم: 30 نوفمبر 2026
📲 للتسجيل وتقديم المشاركات: امسح رمز QR الموجود على التصميم أو استخدم رابط التسجيل المخصص للمسابقة.
✨ فكرتك ممكن تكون بداية لتغيير حقيقي في مستقبل المعامل الطبية!

10/22/2026

🔬 Advancing Science Through Global Collaboration
We are proud to announce that Youssef Ghallab, R&D Specialist at REME-D, will participate in the International Society for Neurochemistry (ISN) School 2026, taking place at the University of Port Harcourt, Nigeria, from October 25–31, 2026.
Under the theme “Neurogenetics for Brain Health,” the scientific school brings together researchers and experts to explore advances in neuroscience, genomics, bioinformatics, functional genetics, and molecular research techniques.
At REME-D, we believe that scientific progress begins with continuous learning, knowledge exchange, and investment in scientific talent.
Youssef’s participation reflects our commitment to supporting the professional development of our R&D team, engaging with the global scientific community, and exploring emerging scientific perspectives that contribute to innovation in life sciences.
We remain committed to advancing sustainable and affordable diagnostic solutions designed for African markets through scientific excellence, collaboration, and innovation.
🌍 At REME-D, we invest in people to advance science and improve healthcare across Africa.

10/20/2026

A few moments from Dr. Salma Tammam, CEO of Reme-D, as she speaks at Nile University, highlighting how scientific research and innovation can translate into real-world impact. 🧬

10/18/2026

When Science Moves Beyond the Lab, Innovation Becomes Impact. 🧬

10/15/2026

**When Science Moves Beyond the Lab, Innovation Becomes Impact. 🧬**

**Dr. Salma Tammam | Founder & CEO, Reme-D Inc.**
Because the real power of science lies not only in what we discover, but in what we make possible through it.
But its true potential unfolds when science moves beyond the laboratory to create solutions, build businesses, and address real-world challenges.

On October 19, the School of Biotechnology at Nile University will host **“From Research to Industry: Turning Ideas into Impact,”** bringing together two leaders in the biotechnology industry to explore how scientific discoveries can translate into innovative ventures.

🔬 **Dr. Salma Tammam**
*Beyond the Lab: Turning Academic Research into a Diagnostic Company*

💡 **Dr. Omar Sakr | CEO, Nawah Scientific**
*How to Convert Lab Findings into Business Ideas*

📅 **Date:** October 19, 2026
⏰ **Time:** 12:30 PM – 2:30 PM
📍 **Venue:** Room 127, Tarek Khalil Building, Nile University

10/15/2026

🧬 REME-D at GEPPMA 2026 | Advancing the Future of Precision

10/14/2026

🧬 REME-D at GEPPMA 2026 | Advancing the Future of Precision Medicine
We are proud to sponsor the 5th Annual GEPPMA Conference 2026, hosted at the German University in Cairo, under the theme:
“HER GENOME. HER MEDICINE. PHARMACOGENOMICS RESHAPING WOMEN’S HEALTH.”
As a molecular diagnostics manufacturer, REME-D is committed to advancing access to innovative diagnostic technologies that support scientific progress and the future of personalized healthcare.
🔬 Discover REME-D’s technologies at GEPPMA 2026!
Visit us to explore our MG-NA 32 Automated Nucleic Acid Extraction System & PseeR 16 Real-Time PCR platform, which will be showcased at the conference.
We look forward to connecting with the scientific community, exchanging insights, and exploring new opportunities for collaboration.
📅 October 15, 2026
📍 German University in Cairo (GUC) | Building C, Hall C1.0 | Gate 3
⏰ 9:00 AM – 5:00 PM
Join us at GEPPMA 2026! Meet our team, discover our technologies, and let’s explore how we can advance molecular diagnostics and personalized medicine together.
We look forward to seeing you there!

10/06/2026

🇪🇬 REME-D تهنئ الشعب المصري بذكرى انتصارات أكتوبر المجيدة*

كل عام ومصر وشعبها بخير، ودامت مصر آمنة ومستقرة

نود التنويه بأن يوم الخميس الموافق 8 أكتوبر 2026 إجازة رسمية بالشركة، ويُستأنف العمل يوم الأحد الموافق 11 أكتوبر 2026.
#مصر 🇪🇬

10/05/2026

We were honored to take part in the AXA , where industry leaders gathered to address critical challenges and future opportunities within the One Health ecosystem.

Representing Reme-D ,
Dr. Mohamed Abdullah, Projects Manager – Public Affairs, delivered an engaging presentation showcasing our vision, strategic business roadmap, and key accomplishments in advancing public health solutions.

Our sincere thanks to AXA for organizing this valuable platform and fostering impactful dialogue among healthcare stakeholders. We remain committed to driving sustainable health innovation and looking ahead to future collaborations.

Address

228 Park Avenue S
New York, NY
10003

Opening Hours

Monday	9am - 5pm
Tuesday	9pm - 5am
Wednesday	9am - 5am
Thursday	9am - 5am
Sunday	9am - 5pm

Website

http://reme-d-inc.com/

Alerts

Be the first to know and let us send you an email when Reme-D posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.